Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaun G Goodman

Showing results (41-50 of 515) with videos related to

Pageof 52
Sort By:
Journal of Cardiology|September 19, 2025
Cardiovascular-related hospital visits amongst oncology patients receiving immune checkpoint inhibitors: a population-based cohort studyWei Fang Dai, Steven Habbous, Andrew Yan, et al.
The Canadian Journal of Cardiology|May 10, 2008
How many cardiovascular events can be prevented with optimal management of high-risk Canadians?Daniel T Grima, Lawrence A Leiter, Shaun G Goodman, et al.
The American Journal of Cardiology|November 15, 2020
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial FibrillationJoseph J Lee, Andrew C T Ha, Paul Dorian, et al.
The American Journal of Medicine|February 3, 2009
Predictors and implications of Q-waves in ST-elevation acute coronary syndromesTroy LaBounty, Hitinder S Gurm, Shaun G Goodman, et al.
International Journal of Cardiology|November 3, 2007
Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromesAmit Segev, Bradley H Strauss, Mary Tan, et al.
European Heart Journal|June 6, 2003
The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2Michael C Tjandrawidjaja, Yuling Fu, Shaun G Goodman, et al.
American Heart Journal|March 27, 2007
Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndromeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
American Heart Journal|August 15, 2002
Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic eraShaun G Goodman, Aiala Barr, Anatoly Langer, et al.
European Heart Journal|August 16, 2003
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarctionPaul W Armstrong, Galen Wagner, Shaun G Goodman, et al.
American Heart Journal|March 30, 2006
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory SubstudyShaun G Goodman, Gerardo E Bozovich, Mary Tan, et al.
Pageof 52

Showing results (41-50 of 515) with videos related to

Sort By:
Pageof 52
Journal of Cardiology|September 19, 2025
Cardiovascular-related hospital visits amongst oncology patients receiving immune checkpoint inhibitors: a population-based cohort studyWei Fang Dai, Steven Habbous, Andrew Yan, et al.
The Canadian Journal of Cardiology|May 10, 2008
How many cardiovascular events can be prevented with optimal management of high-risk Canadians?Daniel T Grima, Lawrence A Leiter, Shaun G Goodman, et al.
The American Journal of Cardiology|November 15, 2020
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial FibrillationJoseph J Lee, Andrew C T Ha, Paul Dorian, et al.
The American Journal of Medicine|February 3, 2009
Predictors and implications of Q-waves in ST-elevation acute coronary syndromesTroy LaBounty, Hitinder S Gurm, Shaun G Goodman, et al.
International Journal of Cardiology|November 3, 2007
Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromesAmit Segev, Bradley H Strauss, Mary Tan, et al.
European Heart Journal|June 6, 2003
The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2Michael C Tjandrawidjaja, Yuling Fu, Shaun G Goodman, et al.
American Heart Journal|March 27, 2007
Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndromeAndrew T Yan, Raymond T Yan, Mary Tan, et al.
American Heart Journal|August 15, 2002
Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic eraShaun G Goodman, Aiala Barr, Anatoly Langer, et al.
European Heart Journal|August 16, 2003
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarctionPaul W Armstrong, Galen Wagner, Shaun G Goodman, et al.
American Heart Journal|March 30, 2006
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory SubstudyShaun G Goodman, Gerardo E Bozovich, Mary Tan, et al.
Pageof 52